Customers

In this article, Professor Stefano Seri, Consultant Clinical neurophysiologist of the Epilepsy Surgery programme at Birmingham Children’s Hospital provides a contemporary look at how the imaging modality is optimizing diagnosis and changing paediatric and adult post-surgery outcomes for the better.

HELSINKI, FINLAND (June 1, 2021) – MEGIN is pleased to announce the acquisition of a TRIUX™ neo by The Centre For Cognitive Neuroimaging (CCNi), at the Institute for Neuroscience and Psychology at the University of Glasgow. This research facility will continue its...

HELSINKI, FINLAND (March 4, 2021) – MEGIN is delighted to support Boys Town National Research Hospital® in Nebraska in their journey to revolutionize child and teen brain research at the new Institute for Human Neuroscience. The Institute will be a brand-new 15,000+...

  HELSINKI, FINLAND (November 26, 2020) – MEGIN is delighted to be partnering with Spectrum Health's Helen DeVos Children’s Hospital in Grand Rapids, Michigan, by delivering our fourth-generation technology, the TRIUX™ neo. We are excited to expand the access of...

HELSINKI, FINLAND (October 1st, 2020) – MEGIN is delighted to announce the sale of our fourth-generation technology, the TRIUX™ neo, to The Institute for Learning & Brain Sciences (I-LABS) of the University of Washington, USA. I-LABS is an interdisciplinary center...

Welcome to MEGIN Community!Starting at the end of 2020, MEGIN Community will be available to TRIUX™ neo customers.Coming soon...  Watch and learn Fresh online training courses How can we help you? Contact MEGIN Customer Care Have a question? Need more information?...

HELSINKI, FINLAND (August 05, 2020) – MEGIN is pleased to announce the sale of our Internal Helium Recycler (IHR) to Swinburne University of Technology. Based in Melbourne Australia, Swinburne is a world-class university creating social and economic impacts through...

HELSINKI, FINLAND (JULY 7, 2020) – MEGIN is pleased to announce the sale of our fourth-generation technology, the TRIUX™ neo, to Amsterdam UMC, location VU University Medical Center (VUmc). VUmc is one of the largest care and research institutions in the Netherlands...

HELSINKI, FINLAND (MARCH 31, 2020) – MEGIN is pleased to announce the sale of our fourth-generation technology, the TRIUX™ neo, to the Chinese Academy of Science (CAS)’s Institute of Neuroscience (ION). This is our second MEG sale to China in the last six months,...

HELSINKI, FINLAND (MARCH 24, 2020) – MEGIN is pleased to announce the smooth and successful installation of the TRIUX neo at Cambridge University’s MRC Cognition and Brain Sciences Unit (CBU). In a display of exceptional teamwork between the the MEGIN and MRC CBU’s...

HELSINKI, FINLAND (NOVEMBER 21, 2019) - Arkansas Children’s Hospital is now home to the TRIUX™ neo, the first and only magnetoencephalography system (MEG) in Arkansas. The TRIUX™ neo is MEGIN’s next generation of MEG technology which is used to detect and localize...

HELSINKI, FINLAND (OCTOBER 9, 2019) – MEGIN is pleased to announce the sale of our fourth-generation technology, the TRIUX™ neo, to three internationally renowned neuroscience facilities.  We are looking forward to working with the MRC Cognition and Brain Sciences...